Managing Hormone and Growth Deficiencies
At a Glance
In Oliver-McFarlane syndrome, hormone deficiencies can develop or change over time. Regular pediatric endocrine follow-up tracks growth, thyroid and adrenal function, puberty, and fertility; treatment may include growth hormone, hydrocortisone, puberty hormones, and an emergency adrenal-crisis plan.
The pituitary gland acts as your child’s “master gland,” and in Oliver-McFarlane Syndrome (OMS), it may not produce enough of the hormones needed for growth and development. This is called hypopituitarism. Because these hormone levels can change as your child grows, management is a lifelong process that requires a close partnership with a pediatric endocrinologist [1][2].
Managing Growth and Height
Many children with OMS have growth hormone deficiency (GHD), where the body doesn’t produce enough hormone to grow at a typical rate. This often leads to a significant delay in bone age and a shorter final height [3][4].
- Treatment: If growth-hormone deficiency is formally confirmed, an endocrinologist may prescribe recombinant human growth hormone (rhGH) [5]. This is typically given as a daily injection under the skin.
- Results: While small case reports show positive growth responses in some children, treatment is highly individualized, response is not guaranteed, and it does not treat the underlying genetic disorder or retinal degeneration [3].
- Monitoring: Your doctor will track your child’s “growth velocity” (how fast they are growing) and use blood tests to measure IGF-1, a protein that helps monitor if the dose is too high or too low. Additionally, starting growth hormone can expose or worsen inadequate cortisol or thyroid levels, so doctors must rigorously assess and monitor adrenal and thyroid function before and during treatment [5][6].
Adrenal Insufficiency: A Critical Safety Concern
Some children with OMS develop secondary adrenocortical insufficiency. This means the pituitary gland doesn’t tell the adrenal glands to make cortisol, the “stress hormone” your body needs to handle illness or injury [3][7]. This condition can be life-threatening if not managed carefully.
Daily and Emergency Management
- Daily Medication: Children with confirmed adrenal insufficiency typically take oral hydrocortisone two or three times a day [8].
- Stress Dosing: When your child is sick (especially with a fever or vomiting) or injured, their body needs more cortisol. You will need to follow a “stress dose” schedule provided by your doctor, which often involves doubling or tripling the normal dose [9][10].
- Emergency Kit: Every family must have an emergency injection kit containing a fast-acting form of hydrocortisone. This is used if your child cannot keep medicine down or shows signs of an adrenal crisis, such as extreme weakness, confusion, or fainting [10][11].
ADRENAL CRISIS ACTION PLAN
An adrenal crisis is a medical emergency that can be fatal. If your child has diagnosed adrenal insufficiency, you must have an individualized written plan from your endocrinologist.
EMERGENCY ACTION REQUIRED IF:
- Your child is vomiting or has severe diarrhea and cannot absorb their oral medication.
- Your child shows signs of an adrenal crisis (extreme weakness, confusion, fainting).
DO NOT WAIT FOR A ROUTINE APPOINTMENT:
Puberty and Future Fertility
OMS can cause hypogonadotropic hypogonadism, where the body doesn’t produce the hormones needed to start or complete puberty [12][13].
- Timing: Growth and pubertal development should be followed at routine endocrine visits, based on delayed-puberty triggers such as no breast development by 13, no testicular enlargement by 14, or no menarche by 15 [14].
- Puberty Induction: If puberty doesn’t start on its own, hormones can be given to mimic the natural process. Girls generally receive estrogen very gradually, with a progestogen added later when indicated [14]. For boys, testosterone may be used [15].
- Fertility Considerations: While hormone replacement helps with physical development, fertility planning differs for people with testes and ovaries and should involve an endocrinologist or reproductive specialist early. For boys who hope to have biological children later, specialized treatments like gonadotropin therapy (hCG and FSH) are an individualized fertility-directed regimen, not just a routine replacement during initial pubertal induction [16][17].
The Importance of Ongoing Monitoring
Pituitary deficiencies in OMS can “evolve,” meaning a child who has normal hormone levels today may develop a deficiency a few years from now [2][18]. Standard care involves:
- Regular Blood Work: To check thyroid, growth, and adrenal hormones.
- Growth Charts: To catch any slowing of growth early.
- Bone Age X-rays: To see how your child’s skeleton is maturing [19].
- Medical Alert ID: It is highly recommended that children with adrenal insufficiency wear a medical alert bracelet to ensure emergency responders know they need cortisol [10].
By staying ahead of these hormone changes, you can help your child maintain their energy, reach their growth potential, and navigate puberty with confidence.
Common questions in this guide
Can growth hormone treatment help my child with Oliver-McFarlane syndrome?
Why are cortisol and thyroid tests needed before starting growth hormone?
What should I do if my child with OMS vomits and cannot keep hydrocortisone down?
How are delayed puberty and future fertility managed in OMS?
How often does my child need hormone monitoring?
What is stress dosing for adrenal insufficiency?
Get notified when new evidence is published on Trichomegaly-retina pigmentary degeneration-dwarfism syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Diagnosis and management of hypopituitarism.
Yeliosof O, Gangat M
Current opinion in pediatrics 2019; (31(4)):531-536 doi:10.1097/MOP.0000000000000779.
PMID: 31082937 - 2
Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.
Xiao P, Gu Y, Qi X, et al.
Frontiers in genetics 2025; (16()):1693876 doi:10.3389/fgene.2025.1693876.
PMID: 41321566 - 3
New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.
Du C, Yu T, Liu S, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.
PMID: 41846525 - 4
Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency.
Gahlot M, Goyal A, Singh AKC, et al.
Indian journal of endocrinology and metabolism 2019; (23(4)):446-451 doi:10.4103/ijem.IJEM_300_19.
PMID: 31741904 - 5
Treatment of growth hormone deficiency in children, adolescents and at the transitional age.
Richmond E, Rogol AD
Best practice & research. Clinical endocrinology & metabolism 2016; (30(6)):749-755 doi:10.1016/j.beem.2016.11.005.
PMID: 27974188 - 6
Benchmarking of growth hormone therapy in Hong Kong: ten-year data from the multi-centre GROWTH study.
Fu A, Alimussina M, Anderson J, et al.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2026; (85()):101727 doi:10.1016/j.ghir.2026.101727.
PMID: 42858488 - 7
Central adrenal insufficiency in children and adolescents.
Patti G, Guzzeti C, Di Iorgi N, et al.
Best practice & research. Clinical endocrinology & metabolism 2018; (32(4)):425-444 doi:10.1016/j.beem.2018.03.012.
PMID: 30086867 - 8
Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.
Ceccato F, Scaroni C
Clinical chemistry and laboratory medicine 2019; (57(8)):1125-1135.
PMID: 30427776 - 9
Treatment and Prevention of Adrenal Crisis and Family Education
Çamtosun E, Sangün Ö
Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.
PMID: 39713905 - 10
Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.
Miller BS, Spencer SP, Geffner ME, et al.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.
PMID: 30819831 - 11
Adrenal crisis: prevention and management in adult patients.
Dineen R, Thompson CJ, Sherlock M
Therapeutic advances in endocrinology and metabolism 2019; (10()):2042018819848218 doi:10.1177/2042018819848218.
PMID: 31223468 - 12
Fertility outcomes and management of long-term pubertal testosterone replacement sequelae in Oliver-McFarlane syndrome: a case report and literature review.
Moshe S, Dekel Y, Oron G, Kabha M
AME case reports 2026; (10()):116 doi:10.21037/acr-2026-0024.
PMID: 42299415 - 13
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532 - 14
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.
Nordenström A, Ahmed SF, van den Akker E, et al.
European journal of endocrinology 2022; (186(6)):G9-G49 doi:10.1530/EJE-22-0073.
PMID: 35353710 - 15
Delayed puberty.
Butler G, Purushothaman P
Minerva pediatrica 2020; (72(6)):484-490 doi:10.23736/S0026-4946.20.05968-X.
PMID: 32748610 - 16
Current perspectives on the pharmacologic treatment of boys and adolescents with congenital hypogonadotropic hypogonadism.
Rey RA, Grinspon RP
Expert opinion on pharmacotherapy 2026; 1-13 doi:10.1080/14656566.2026.2741490.
PMID: 42802581 - 17
[Puberty induction in boys with congenital isolated hypogonadotropic hypogonadism].
Kokoreva KD, Chugunov IS, Kareva MA, Bezlepkina OB
Problemy endokrinologii 2023; (69(1)):59-67 doi:10.14341/probl13141.
PMID: 36842078 - 18
Pituitary Magnetic Resonance Imaging as a Prognostic Factor of Pituitary Insufficiency-The Follow-Up Analysis of a Cohort of Children With Pituitary Stalk Interruption Syndrome.
Chrzanowska J, Jacków-Nowicka J, Bodetko A, et al.
Clinical endocrinology 2026; (105(2)):231-236 doi:10.1111/cen.70129.
PMID: 41844520 - 19
Differential diagnosis between constitutional delay of growth and puberty, idiopathic growth hormone deficiency and congenital hypogonadotropic hypogonadism: a clinical challenge for the pediatric endocrinologist.
Galazzi E, Persani LG
Minerva endocrinologica 2020; (45(4)):354-375 doi:10.23736/S0391-1977.20.03228-9.
PMID: 32720501
This page is for informational purposes only and does not replace medical advice. Your child’s pediatric endocrinologist must individualize hormone treatment, sick-day dosing, and emergency instructions; call emergency services for suspected adrenal crisis.